FTO-IN-15
FTO-IN-15 (Compound 8a) is a potent and selective dual-competitive FTO inhibitor with an IC50 of 43.7 nM, showing high selectivity over ALKBH3 and ALKBH5. FTO-IN-15 substantially inhibits FTO demethylation by simultaneously occupying the substrate and 2-oxoglutarate (2-OG) pockets. FTO-IN-15 can be used for the research of acute myeloid leukemia (AML).
For research use only. We do not sell to patients.
- Formula: C20H17Cl2N3O6
- Molecular Weight:466.27
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
IC50: 1.3 μM[1]
In Vitro
FTO-IN-15 (compound 8a) (0-50 μM) functions as a competitive inhibitor for the 2-OG binding pocket of FTO, as evidenced by the dose-dependent reversal of its inhibitory activity by increasing concentrations of 2-OG in a cell-free enzymatic assay[1].
FTO-IN-15 exhibits potent FTO inhibitory activity, with an IC50 of 43.7 nM in a cell-free dot blot assay and 1.3 μM in a PAGE-based demethylation assay[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
Molecular Weight 466.27
-
Formula C20H17Cl2N3O6
-
SMILES
O=C(/C=C/C(NCCNC(C1=CC(Cl)=C(C(Cl)=C1)NC2=CC=CC=C2C(O)=O)=O)=O)O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)